Why some providers are opting out of BCBS’ $2.8B settlement

A judge has approved Blue Cross Blue Shield's $2.8 billion settlement with providers. However, some providers are opting out, arguing that it doesn't go far enough.

Editor's Pick

Top Story A Judge Approved BCBS' $2.8B Settlement. Why Some Providers Are Opting Out A judge has approved Blue Cross Blue Shield's $2.8 billion settlement with providers. However, some providers are opting out, arguing that it doesn't go far enough. Sponsored 2025 Report: Why Employers Are Rethinking Navigation & GLP-1 Coverage Presented by Quantum Health A majority of benefit consultants say self-insured employers should embrace independent healthcare navigation to boost member experience, strengthen clinical integration, and cut costs, according to the 2025 Benefits Sentiment Index. The report also reveals a growing trend: employers are covering GLP-1 drugs—but only if outcomes can be measured. Get the full report today! Shaping the Future of AI in Healthcare At INVEST Digital Health, experts will tackle the tough questions: How do we measure AI's impact? What drives differentiation in a crowded market? And how can trust be built while adopting new technologies? Be part of the conversation, and the connections that move healthcare forward. Register Today

Featured News

Cleveland Clinic Taps Dyania Health to Speed Up Clinical Trials with AI Cleveland Clinic is expanding its use of Dyania Health's AI platform across the health system to speed up clinical trial recruitment. The system quickly scans patient records to identify eligible participants, aiming to give more patients access to trials and speed up development timelines for new therapies. Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines Obesity and type 2 diabetes are among the cardiometabolic diseases included in Novo Nordisk's R&D pact with Replicate Bioscience, a deal that could pay out up to $550 million. Startup Replicate specializes in therapies and vaccines based on self-replicating RNA. Putting SDOH Data to Work for Systems and Patients For healthcare leaders, actionable SDOH insights are key to advancing equity and improving patient outcomes. By investing in comprehensive engagement strategies and leveraging technology, the healthcare industry can build trust, address barriers to care, and ensure that no patient falls through the cracks.

Video   California's efforts to rein in PBMs On Debunked, Paul Markovich, president and CEO of Ascendiun, discussed a proposed California bill that would delink PBM compensation from drug list prices. He cited a recent Health Affairs study that found the change could generate nearly $100 billion in savings.

Sponsored The Definitive Guide to Medical Billing Outsourcing: 5 Top Companies Presented by Global Healthcare Resource In today's healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you? Learn More.

Resources

MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe